Y-mAbs Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Y-mAbs Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2017 to Q2 2024.
  • Y-mAbs Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 100M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 100M 0 0% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 100M 0 0% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 100M 0 0% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 100M 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 100M 0 0% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 100M 0 0% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 100M 0 0% Dec 31, 2022 10-K 2024-02-29
Q3 2022 100M 0 0% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 100M 0 0% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 100M 0 0% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 100M 0 0% Dec 31, 2021 10-K 2023-03-30
Q3 2021 100M 0 0% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 100M 0 0% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 100M 0 0% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 100M 0 0% Dec 31, 2020 10-K 2022-03-01
Q3 2020 100M 0 0% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 100M 0 0% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 100M 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 100M 0 0% Dec 31, 2019 10-K 2022-03-01
Q3 2019 100M 0 0% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 100M Jun 30, 2019 10-Q 2019-08-14
Q1 2019 100M Mar 31, 2019 10-Q 2019-05-10
Q4 2018 100M +50M +100% Dec 31, 2018 10-K 2020-03-12
Q3 2018 100M Sep 30, 2018 10-Q 2018-11-13
Q4 2017 50M Dec 31, 2017 10-K 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.